N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds

   
   

The present invention provides compounds of Formula I: ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula I.

La presente invenzione fornisce i residui della formula I: ## del ## STR1 in cui la X, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 e R.sup.6 hanno c'è ne dei valori definiti nella specifica, così come le composizioni farmaceutiche che contengono i residui. L'invenzione inoltre fornisce i metodi terapeutici così come i processi e gli intermediari utili per la preparazione dei residui della formula I.

 
Web www.patentalert.com

< Human kinase and polynucleotides encoding the same

< Therapeutic and diagnostic tools for impaired glucose tolerance conditions

> Benzimidazole compounds as ORL1-receptor agonists

> Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists

~ 00164